查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856340

口腔內醫療器材市場按產品類型、藥物類別、技術、最終用戶和應用分類－2025年至2032年全球預測

Buccal Cavity Devices Market by Product Type, Drug Class, Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，口腔內醫療器材市場規模將達到 76.9 億美元，複合年成長率為 10.85%。

關鍵市場統計數據
基準年 2024 33.7億美元
預計年份：2025年 37.3億美元
預測年份 2032 76.9億美元
複合年成長率 (%) 10.85%

本文簡要說明了口腔矯正器的基本原理、臨床依據以及影響近期發展和商業性重點的技術因素。

口腔給藥裝置代表了藥物製劑科學與以患者為中心的給藥方式之間的關鍵交匯點，它能夠快速實現全身吸收和靶向粘膜治療，並避免了腸外給藥的侵入性。本導言組裝了當前的治療和商業性格局，重點介紹了關鍵的給藥形式、常見的治療靶點以及推動口腔給藥從小眾應用走向主流的臨床促進因素。透過將口腔給藥方案置於更廣泛的腸外全身給藥系統中，本分析著重闡述了這些技術在起效速度、生物有效性和減少胃腸道暴露方面的獨特價值。

臨床上，口腔黏膜給藥途徑對需要快速緩解症狀、可控荷爾蒙給藥以及簡化慢性病治療依從性的患者群體具有吸引力。技術上，從黏膜黏附劑到奈米顆粒增強載體等製劑創新，正在拓展可可靠地遞送至口腔黏膜的活性成分範圍。從商業性角度來看，支付方和醫療服務提供者越來越接受治療方法。因此，本引言為深入分析支撐該領域近期發展軌蹟的不斷變化的監管預期、生產策略和跨部門合作奠定了基礎。

科學突破、監管參與和患者期望的融合如何改變研發重點並加速口腔給藥系統的應用

口腔給藥裝置領域正經歷著變革性的轉變，這主要得益於科學、監管和病患行為趨勢的融合，這些趨勢正在重新定義產品開發的重點。製劑科學的進步正在加速從簡單的可溶性薄膜和噴霧劑向黏膜黏附平台和奈米顆粒增強載體的轉變，這些載體能夠遞送更大的分子並改善藥物動力學特性。這些科學進步迫使裝置設計者整合精準給藥、定量傳遞和生物響應材料，以解決黏膜吸收的個體差異並提高治療的一致性。

監管機構正透過有針對性的指導和適應性審查路徑，展現出對新型給藥方式的積極態度，從而降低了優先開展早期對話和可靠轉化研究的研發人員面臨的技術不確定性。同時，支付方對真實世界療效的嚴格審查提高了證明依從性獲益和後續成本抵消的門檻，促使生產商將證據生成計劃納入其研發項目。此外，患者對便捷易用療法的期望也推動了包裝、給藥人體工學和數位依從性支持等方面的設計創新。綜上所述，這些變化促使相關人員採取整合策略，將製劑創新與監管計畫和證據生成結合，加​​速新療法的推廣應用。

2025年美國關稅及戰略因應措施對採購、製造及上市時間所產生的累積商業性及營運影響

2025年關稅的實施和貿易政策的調整，為全球醫藥輔料、特殊聚合物以及口腔矯正器所需精密製造零件的供應鏈帶來了新的摩擦。這些政策變化提高了進口原料的成本，並限制了先前依賴集中式供應商網路的製造商的採購靈活性。為此，許多公司調整了籌資策略，力求實現供應商多元化和製造地區域化，以降低關稅造成的價格波動風險。

除了採購之外，關稅環境也促使企業在關稅差異最大的市場進行技術轉移和在地化生產合作，加速了製劑研發和設備組裝能力在終端市場附近的建立。這種重組縮短了前置作業時間，提高了對當地監管和市場需求的應對力，但也需要企業在合格和品質系統方面進行大量前期投資。值得注意的是，擁有靈活平台技術的開發商，例如模組化貼片製造和可擴展的薄膜流延工藝，更有能力應對成本波動，同時保持產品品質。展望未來，更加重視策略採購、採用能夠對沖政策波動的合約條款以及提高流程效率，很可能成為在貿易政策可能對成本結構和產品上市時間產生重大影響的環境下，增強商業性韌性的關鍵手段。

將產品架構、治療層級、給藥技術、終端使用者管道和特定應用開發需求連結起來的可操作細分情報

了解市場區隔對於確定口腔黏膜治療器材領域的研發路徑和商業投資優先順序至關重要，因為製劑類型、治療標靶、技術方法、使用者環境和臨床應用都會對產品設計、監管策略和上市策略產生不同的影響。依產品類型分類，市場涵蓋口腔黏膜、口腔貼片、口腔片劑、凝膠和口腔噴霧。黏膜又分為黏膜黏附型和可溶性型，分別適用於不同的停留時間和釋放動力學。貼片採用基質或儲庫結構，可實現持續擴散或可控脈衝釋放。片劑有控制釋放基質和即時釋製劑，可用於維持治療和搶救治療。凝膠種類繁多，從延長與黏膜接觸時間的生物黏附基質到用於水合控制釋放的水凝膠系統，應有盡有。口腔噴霧劑則提供定量和多劑量兩種劑型，方便快速給藥。

荷爾蒙療法、局部麻醉劑、尼古丁替代療法和鴉片類藥物製劑各自需要獨特的藥理學、安全性和監管方面的考量。奈米顆粒平台可以改善黏膜滲透性和靶向性，但需要更全面的表徵。終端用戶分為家庭醫療保健、醫院和零售藥局分銷，這會影響包裝、標籤和病患教育策略。應用領域涵蓋心血管治療、雌激素和睪固酮激素替代療法、抗生素和抗病毒藥物等感染疾病、急性和慢性疼痛管理以及戒菸。將產品架構和證據產生與這些相互交織的細分維度相匹配，可以幫助製造商更好地針對臨床路徑、支付者互動和通路策略，從而最佳化產品應用。

對美洲、歐洲、中東和非洲以及亞太地區的監管策略、報銷影響、在地化生產和實施路徑的區域性影響

了解美洲、歐洲、中東和非洲以及亞太地區的細微差別對於策略規劃至關重要，因為區域動態會影響口腔矯正器的監管路徑、報銷框架、生產重點和推廣時間表。在美洲，監管機構已為組合藥物制定了明確的路徑，並展現了與研發人員務實的合作。市場滲透率的促進因素包括支付方對提高依從性益處的認可，以及醫院和門診管道對速效、急診和荷爾蒙補充療法的青睞。美洲的生產能力專注於大規模聚合物加工和無菌過濾，從而支持高需求適應症的快速商業化。

歐洲、中東和非洲的監管環境各不相同，在協調統一的同時，各地區也存在著強調早期對話和區域性臨床證據的特定要求。報銷決定通常取決於真實世界療效的證明，這迫使夥伴關係制定上市後證據計畫。該地區也為與製造外包建立市場推廣合作關係提供了機會，這些合作關係能夠滿足不同的監管要求。最後，亞太地區兼具患者快速接受度和對成本高度敏感的支付方環境。該地區的市場涵蓋了從擁有強大奈米顆粒和黏合劑研發能力的高科技中心，到那些在地化生產和簡化法規核准流程能夠加速市場准入的地區。在每個地區，成功的策略都應平衡全球產品標準和有針對性的本地實施計劃，以應對監管方面的細微差別、支付方的需求以及分銷物流。

策略聯盟、製造專業化、智慧財產權和證據產生如何決定口服給藥領域的競爭定位和合作機會

在整個價值鏈中，口腔活性藥物公司之間的競爭與合作動態正在重塑投資重點和合作模式。創新製藥公司正日益探索口腔給藥平台，以彌補口服或注射途徑的局限性，從而實現產品差異化；而專業醫療器材製造商則專注於可擴展、可重複的生產方法，以確保劑量的一致性和用戶接受度。合約研發受託製造廠商）透過提供檢驗的薄膜、貼片和噴霧劑製程模組，在加速新參與企業產品上市方面發揮關鍵作用，這些模組能夠在不損害品質系統的前提下加速技術轉移。

製劑科學家和器械工程師之間的合作正變得日益戰略化，重點在於共同開發可授權和聯合品牌化的專有黏合聚合物和給藥裝置。同時，對輔料化學和器械幾何結構相關智慧財產權的控制正成為競爭定位的關鍵。投資於整合臨床項目的公司，透過將藥物動力學/藥效學橋接研究與依從性和患者偏好數據相結合，可以在與支付方談判和藥品目錄納入方面獲得優勢。最後，供應鏈韌性（體現在輔料的多來源採購和區域組裝能力上）使公司能夠在市場和政策壓力下保持不間斷的供應，從而脫穎而出。

制定切實可行的策略重點和營運介入措施，以加速研發進度，確保供應彈性，並確保支付方和醫療服務提供者採用口腔系統。

產業領導者必須採取務實且以證據為基礎的策略，充分利用口腔給藥領域的科學發展勢頭，同時管控監管、商業和供應風險。應優先開發模組化平台，使其能夠適應各種劑型，包括薄膜、貼片、凝膠和噴霧劑，從而使配方經驗和生產資源能夠跨適應症重新部署。同時，應儘早納入可靠的臨床證據和真實世界證據設計，以了解支付方在報銷決策中日益關注的因素，例如依從性、病患報告結局和衛生經濟學終點。從監管角度來看，應儘早與監管機構溝通，明確對組合藥物的預期，並為新型輔料和奈米顆粒技術建立可接受的轉化依據。

在營運方面，我們將拓展關鍵輔料供應商網路，並尋求區域性生產夥伴關係，以縮短前置作業時間，同時降低關稅和貿易風險。我們將投資於以患者為中心的設計能力，以提高產品接受度並最大限度地減少給藥錯誤，並探索能夠產生差異化真實世界數據的數位依從性技術。最後，為了降低規模化生產風險，我們將與合約開發和製造外包夥伴進行有針對性的合作，並透過涵蓋製劑化學、器械形態和生產流程的周密智慧財產權策略來保護創新成果。這些在研發、監管和商業部門協調的行動，將加速產品推廣應用並縮短價值實現時間。

概述調查方法和資料來源，詳細介紹支持報告結論的多源調查方法、同儕檢驗、資料三角測量和品管。

本分析所依據的研究結合了對官方監管指南、專利概況和臨床試驗註冊資訊的系統性回顧，以及對正在積極開發或評估口服藥物平台的製劑科學家、法規事務專家和商業負責人進行的結構化訪談。二級資訊來源包括關於黏膜藥物動力學的同行評審文獻、關於黏膜黏附聚合物科學的白皮書以及器械製造的技術標準。主要研究包括與相關領域專家的討論，以檢驗製劑可行性、生產瓶頸和預期證據的假設。

透過資料三角驗證確保了研究結果的穩健性。訪談中獲得的定性見解與監管申報文件和臨床試驗結果進行了交叉比對，並透過供應商審核和設施產能評估驗證了生產和供應鏈方面的觀察結果。調查方法強調文獻和訪談資料擷取標準的透明度，並在資料有限或有分歧的情況下採用保守的解釋。品管步驟包括由獨立專家對結論進行同行評審，以及情境測試，以確保策略建議能夠應用於不同的監管和貿易環境。

本文簡要摘要了口腔給藥創新在商業性和臨床機會交會點上的策略意義和未來發展方向。

口腔黏膜給藥裝置在現代醫療保健中佔有重要的策略地位，其獨特的臨床和商業性優勢不僅帶來便利，還能帶來實際的益處，例如改善藥物動力學和提高病患依從性。製劑創新、監管互動、支付方證據要求以及供應鏈策略之間的相互作用，將決定哪些產品能夠被廣泛採用，哪些產品仍將作為專科產品。那些能夠將平台靈活性與嚴格的證據產生、強大的智慧財產權保護和穩定的供應相結合的公司，更有可能獲得優先進入藥品目錄和臨床路徑的機會。

展望未來，黏合劑化學將持續進步，奈米顆粒在遞送難溶活性成分方面的應用將日益廣泛，數位化黏附工具也將更深入地整合到產品中。對策略夥伴關係和在地化生產的投資將有助於降低政策衝擊帶來的風險，並加快產品上市速度。最終，隨著口服給藥技術在心血管疾病、荷爾蒙治療、感染疾病、疼痛管理和戒菸等領域的應用不斷擴展，那些能夠協調一致地執行研發、監管和商業計劃的領先企業將獲得巨大的競爭優勢。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 具有可控藥物釋放動力學的3D列印個人化口腔膜的出現
  • 利用生物黏附微陣列貼片在口腔內進行延長藥物釋放
  • 開發用於即時監測口腔黏膜健康參數的智慧頰部感測器
  • 整合人工智慧驅動的設計演算法，最佳化頰部裝置的貼合度與患者舒適度
  • 使用抗菌聚合物塗層降低黏性口腔片劑的感染風險
  • 聚合物共混配方的進展可延長藥物在口腔黏膜表面的停留時間
  • 牙科和製藥公司合作開發多功能頰部治療平台

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按產品類型分類的口腔內器材市場

  • 口腔膜
    • 黏合膜
    • 可溶性薄膜
  • 頰部貼片
    • 矩陣補丁
    • 水庫補丁
  • 口腔片劑
    • 控制釋放片
    • 即時釋片
  • 凝膠
    • 生物黏合凝膠
    • 水凝膠
  • 口腔噴霧劑
    • 定量噴霧
    • 多劑量噴霧

9. 按藥物類別分類的口服器材市場

  • 荷爾蒙
  • 局部麻醉劑
  • 尼古丁
  • 鴉片類藥物

第10章 按技術分類的口腔內器材市場

  • 傳統配送
  • 奈米顆粒增強遞送

第11章 依最終使用者分類的口腔內器材市場

  • 家庭醫療保健
  • 醫院
  • 零售藥房

第12章 按應用分類的口腔內器材市場

  • 心血管治療
  • 荷爾蒙替代療法
    • 雌激素
    • 男性荷爾蒙
  • 感染疾病
    • 抗菌劑
    • 抗病毒藥物
  • 疼痛管理
    • 急性疼痛
    • 慢性疼痛
  • 禁止抽煙

第13章 口腔內器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 口腔內器材市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國口腔內醫療器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Dentsply Sirona Inc.
    • 3M Company
    • Danaher Corporation
    • Straumann Holding AG
    • Envista Holdings Corporation
    • Align Technology, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Ivoclar Vivadent AG
    • Coltene Holding AG
    • Patterson Companies, Inc.
Product Code: MRR-742BD517C295

The Buccal Cavity Devices Market is projected to grow by USD 7.69 billion at a CAGR of 10.85% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.37 billion
Estimated Year [2025] USD 3.73 billion
Forecast Year [2032] USD 7.69 billion
CAGR (%) 10.85%

A concise orientation to buccal cavity device fundamentals, clinical rationales, and technological enablers shaping near-term development and commercial priorities

Buccal cavity devices represent a critical intersection of drug formulation science and patient-centred delivery, offering rapid systemic uptake and targeted mucosal therapy without the invasiveness of parenteral routes. This introduction frames the current therapeutic and commercial landscape by outlining core delivery formats, prevailing therapeutic targets, and the clinical drivers that have elevated buccal approaches from niche applications to mainstream consideration. By situating buccal solutions within the broader continuum of non-oral systemic delivery, the analysis clarifies where these technologies deliver unique value in terms of onset speed, bioavailability, and reduced gastrointestinal exposure.

Clinically, buccal approaches appeal to patient populations requiring rapid symptomatic relief, controlled hormone administration, or simplified adherence pathways for chronic conditions. Technologically, formulation innovations-ranging from mucoadhesives to nanoparticle-enhanced carriers-have expanded the range of actives that can be reliably delivered across the buccal mucosa. From a commercial standpoint, payers and providers are increasingly receptive to therapies that demonstrate measurable adherence improvements and that reduce downstream healthcare utilization through improved therapeutic outcomes. The introduction therefore sets the stage for deeper analysis on shifting regulatory expectations, manufacturing strategies, and cross-sector collaborations that underpin the sector's near-term trajectory.

How converging scientific breakthroughs, regulatory engagement, and patient expectations are reshaping development priorities and accelerating adoption of buccal delivery systems

The buccal device environment is undergoing transformative shifts driven by converging scientific, regulatory, and patient-behavior trends that are redefining product development priorities. Advances in formulation science have accelerated the transition from simple soluble films and sprays to engineered mucoadhesive platforms and nanoparticle-enhanced carriers capable of delivering larger molecules and improving pharmacokinetic profiles. These scientific advances, in turn, are prompting device designers to integrate precision dosing, metered delivery, and bioresponsive materials to address variability in mucosal absorption and to improve therapeutic consistency.

Regulatory authorities have signaled a greater willingness to engage on novel delivery formats through targeted guidance and adaptive review pathways, which has reduced technical uncertainty for developers who prioritize early dialogue and robust bridging studies. Simultaneously, payer scrutiny around real-world effectiveness has raised the bar for demonstrating both adherence benefits and downstream cost offsets, incentivizing manufacturers to embed evidence-generation plans into development programs. Finally, patient expectations for discreet, easy-to-use therapies have elevated design thinking around packaging, administration ergonomics, and digital adherence supports. Taken together, these shifts encourage stakeholders to pursue integrated strategies that align formulation innovation with regulatory planning and evidence generation to accelerate adoption.

Cumulative commercial and operational consequences of 2025 United States tariff measures and the strategic responses shaping procurement, manufacturing, and time to market

The imposition of tariffs and trade policy adjustments in 2025 introduced new frictions to the global supply chain for pharmaceutical excipients, specialized polymers, and precision manufacturing components essential to buccal devices. These policy changes have amplified the cost of imported raw materials and limited sourcing flexibility for manufacturers that had previously relied on concentrated supplier networks. In response, many companies shifted procurement strategies toward diversified supplier bases and regionalized manufacturing footprints to mitigate exposure to tariff-driven price volatility.

Beyond procurement, the tariff environment incentivized technology transfer and local production partnerships in markets where tariff differentials were most acute, accelerating the establishment of formulation and device assembly capabilities closer to end markets. This realignment reduced lead times and improved responsiveness to local regulatory and market requirements, but it also required significant upfront investment in qualification and quality systems. Importantly, developers with flexible platform technologies-such as modular patch fabrication or scalable film-casting processes-were better positioned to absorb cost shocks while maintaining product quality. Going forward, strategic sourcing, contractual terms that hedge against policy volatility, and greater emphasis on process efficiency will be essential levers for commercial resilience in a landscape where trade policy can materially affect cost structures and time to market.

Practical segmentation intelligence linking product architectures, therapeutic classes, delivery technologies, end user channels, and application-specific development imperatives

Understanding segmentation is fundamental to prioritizing development pathways and commercial investments in the buccal device space, because formulation type, therapeutic target, technological approach, user environment, and clinical application each exert distinct influence on product design, regulatory strategy, and go-to-market execution. Product-wise, the market spans buccal film, buccal patch, buccal tablet, gel, and oral spray formats. Films divide into mucoadhesive and soluble subtypes, each suited to different residence times and release kinetics, while patches can follow matrix or reservoir architectures to enable either sustained diffusion or controlled pulsatile release. Tablet formats present options between controlled-release matrices and instant-release formulations, enabling both maintenance and rescue therapies. Gels range from bioadhesive matrices that prolong mucosal contact to hydrogel systems engineered for hydration-controlled release, and oral sprays offer both metered-dose and multi-dose modalities for rapid administration.

Therapeutic segmentation also matters: hormone therapies, local anesthetics, nicotine replacement, and opioid formulations each pose unique pharmacology, safety, and regulatory considerations. Technology choices-conventional delivery versus nanoparticle-enhanced systems-drive formulation complexity and clinical endpoints; nanoparticle platforms can improve mucosal permeability and targetability yet require more extensive characterization. End users split across home healthcare, hospital settings, and retail pharmacy distribution, which dictates packaging, labeling, and patient education strategies. Application areas extend across cardiovascular treatment, hormone replacement with estrogen and testosterone subsegments, infectious diseases with antimicrobial and antiviral subcategories, pain management spanning acute and chronic pain, and smoking cessation. By aligning product architecture and evidence generation to these intersecting segmentation axes, manufacturers can better target clinical pathways, payer conversations, and channel strategies to optimize uptake.

Regional implications for regulatory strategy, reimbursement engagement, manufacturing localization, and adoption pathways across the Americas, Europe Middle East & Africa, and Asia Pacific

Regional dynamics shape regulatory pathways, reimbursement frameworks, manufacturing priorities, and adoption timelines for buccal cavity devices, so understanding the nuanced differences across the Americas, Europe Middle East & Africa, and Asia-Pacific is essential for strategic planning. In the Americas, regulatory agencies have established clear pathways for combination products and demonstrate pragmatic engagement with developers; market uptake is driven by payer receptivity to adherence benefits and by strong hospital and outpatient clinic channels that favor rapid-acting, rescue, and hormone-replacement therapies. Manufacturing capabilities in the Americas emphasize large-scale polymer processing and sterile filtration, supporting rapid commercialization for high-volume indications.

In Europe, Middle East & Africa, the regulatory landscape is heterogeneous, with harmonization efforts coexisting alongside region-specific requirements that favor early dialogues and localized clinical evidence. Reimbursement decisions frequently hinge on demonstrated real-world outcomes, pushing sponsors to design post-launch evidence programs. The region also presents opportunities for route-to-market partnerships with contract manufacturers that can navigate diverse regulatory expectations. Finally, Asia-Pacific exhibits a combination of rapid patient adoption and cost-sensitive payer environments; markets within the region vary from high-tech hubs with strong capabilities in nanoparticle and mucoadhesive research to jurisdictions where localized manufacturing and streamlined regulatory acceptance can accelerate market entry. Across regions, successful strategies balance global product standards with targeted local execution plans that address regulatory nuances, payer demands, and distribution logistics.

How strategic alliances, manufacturing specialization, intellectual property and evidence generation are defining competitive positioning and partnership opportunities in buccal delivery

Competitive and collaborative dynamics among companies active in buccal delivery are reshaping investment priorities and partnership models across the value chain. Innovator pharmaceutical companies are increasingly exploring buccal platforms to differentiate products where oral or injectable routes present limitations, while specialty device manufacturers are focused on scalable, reproducible manufacturing methods that ensure consistent dosing and user acceptability. Contract development and manufacturing organizations play a pivotal role in reducing time to market for emerging entrants by offering validated process modules for films, patches, and sprays that accelerate technology transfer without compromising quality systems.

Collaborations between formulation scientists and device engineers are becoming more strategic, emphasizing co-development of proprietary mucoadhesive polymers and dosing hardware that can be licensed or co-branded. At the same time, intellectual property management around excipient chemistries and device geometries has grown more central to competitive positioning. Companies that invest in integrated clinical programs-pairing PK/PD bridging studies with adherence and patient preference data-gain leverage in payer negotiations and formulary placement. Finally, supply chain resilience, evidenced by multi-sourced excipients and regional assembly capabilities, differentiates firms in terms of their ability to maintain uninterrupted supply under market and policy stressors.

Actionable strategic priorities and operational interventions to accelerate development timelines, assure supply resilience, and secure payer and provider adoption for buccal systems

Industry leaders must adopt pragmatic, evidence-driven strategies to capitalize on the scientific momentum in buccal delivery while managing regulatory, commercial, and supply-side risks. Prioritize modular platform development that allows adaptation across films, patches, gels, and sprays so that formulation learnings and manufacturing assets can be redeployed across indications. Simultaneously, embed robust clinical and real-world evidence designs early to capture adherence, patient-reported outcomes, and health economic endpoints that payers increasingly require for reimbursement decisions. From a regulatory perspective, pursue early engagement with authorities to clarify expectations for combination products and to establish acceptable bridging arguments for novel excipients or nanoparticle technologies.

Operationally, diversify supplier networks for critical excipients and pursue regional manufacturing partnerships to mitigate tariff and trade risks while reducing lead times. Invest in patient-centred design features that improve acceptability and minimize administration errors, and consider digital adherence technologies that can generate differentiating real-world data. Finally, pursue targeted collaborations with contract development and manufacturing partners to de-risk scale-up, and protect innovation through a deliberate IP strategy that covers formulation chemistries, device geometries, and manufacturing processes. These actions, when coordinated across R&D, regulatory, and commercial functions, will accelerate adoption and reduce time-to-value realization.

Methodological overview detailing the multi-source research approach, expert validation, data triangulation, and quality controls that support the report's conclusions

The research underpinning this analysis combined systematic review of public regulatory guidance, patent landscapes, and clinical trial registries with structured interviews of formulation scientists, regulatory affairs specialists, and commercial leads who are actively developing or evaluating buccal platforms. Secondary sources included peer-reviewed literature on mucosal pharmacokinetics, white papers on mucoadhesive polymer science, and technical standards for device manufacturing. Primary research consisted of targeted expert consultations to validate assumptions around formulation feasibility, manufacturing bottlenecks, and evidence expectations.

Data triangulation ensured robustness: qualitative insights from interviews were cross-checked against regulatory filings and clinical study outcomes, while manufacturing and supply chain observations were corroborated through supplier audits and facility capability assessments. The methodology emphasized transparency in inclusion criteria for literature and interview sampling, and it applied conservative interpretation where data were limited or divergent. Quality control steps included peer review of conclusions by independent domain experts and scenario testing of strategic recommendations to ensure they hold under alternative regulatory and trade environments.

Concise synthesis of strategic implications and future directions that summarize where commercial and clinical opportunities converge for buccal delivery innovations

Buccal cavity devices occupy a strategically important niche in modern therapeutics, offering unique clinical and commercial advantages that extend beyond convenience to tangible pharmacokinetic and adherence gains. The interplay of formulation innovation, regulatory engagement, payer evidence requirements, and supply chain strategy will determine which products achieve broad adoption versus those that remain specialized. Companies that align platform flexibility with rigorous evidence generation, robust IP protection, and supply resilience will secure preferred access to formularies and clinical pathways.

Looking ahead, the sector will likely see continued refinement of mucoadhesive chemistries, wider adoption of nanoparticle-enabled delivery for challenging actives, and deeper integration of digital adherence tools into product offerings. Strategic partnerships and regional manufacturing investments will reduce exposure to policy shocks and improve speed to market. Ultimately, leaders who execute coordinated R&D, regulatory, and commercial plans will capture disproportionate advantage as buccal delivery expands across cardiovascular, hormonal, infectious disease, pain management, and smoking cessation applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Emergence of 3D printed personalized buccal films with controlled drug release kinetics
  • 5.2. Adoption of bioadhesive microarray patches for extended medication delivery in the oral cavity
  • 5.3. Development of smart buccal sensors for real time monitoring of oral mucosal health parameters
  • 5.4. Integration of AI driven design algorithms to optimize buccal cavity device fit and patient comfort
  • 5.5. Use of antibacterial polymer coatings to reduce infection risk in mucoadhesive buccal tablets
  • 5.6. Advancements in polymer blend formulations to enhance residence time on buccal mucosa surfaces
  • 5.7. Collaboration between dental and pharmaceutical sectors for multifunctional buccal therapeutic platforms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Buccal Cavity Devices Market, by Product Type

  • 8.1. Buccal Film
    • 8.1.1. Mucoadhesive Film
    • 8.1.2. Soluble Film
  • 8.2. Buccal Patch
    • 8.2.1. Matrix Patch
    • 8.2.2. Reservoir Patch
  • 8.3. Buccal Tablet
    • 8.3.1. Controlled-Release Tablet
    • 8.3.2. Instant-Release Tablet
  • 8.4. Gel
    • 8.4.1. Bioadhesive Gel
    • 8.4.2. Hydrogel
  • 8.5. Oral Spray
    • 8.5.1. Metered-Dose Spray
    • 8.5.2. Multi-Dose Spray

9. Buccal Cavity Devices Market, by Drug Class

  • 9.1. Hormones
  • 9.2. Local Anesthetics
  • 9.3. Nicotine
  • 9.4. Opioids

10. Buccal Cavity Devices Market, by Technology

  • 10.1. Conventional Delivery
  • 10.2. Nanoparticle Enhanced Delivery

11. Buccal Cavity Devices Market, by End User

  • 11.1. Home Healthcare
  • 11.2. Hospital
  • 11.3. Retail Pharmacy

12. Buccal Cavity Devices Market, by Application

  • 12.1. Cardiovascular Treatment
  • 12.2. Hormone Replacement
    • 12.2.1. Estrogen
    • 12.2.2. Testosterone
  • 12.3. Infectious Diseases
    • 12.3.1. Antimicrobial Agents
    • 12.3.2. Antiviral Agents
  • 12.4. Pain Management
    • 12.4.1. Acute Pain
    • 12.4.2. Chronic Pain
  • 12.5. Smoking Cessation

13. Buccal Cavity Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Buccal Cavity Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Buccal Cavity Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Dentsply Sirona Inc.
    • 16.3.2. 3M Company
    • 16.3.3. Danaher Corporation
    • 16.3.4. Straumann Holding AG
    • 16.3.5. Envista Holdings Corporation
    • 16.3.6. Align Technology, Inc.
    • 16.3.7. Zimmer Biomet Holdings, Inc.
    • 16.3.8. Ivoclar Vivadent AG
    • 16.3.9. Coltene Holding AG
    • 16.3.10. Patterson Companies, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BUCCAL CAVITY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BUCCAL CAVITY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BUCCAL CAVITY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MUCOADHESIVE FILM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MUCOADHESIVE FILM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MUCOADHESIVE FILM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MUCOADHESIVE FILM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MUCOADHESIVE FILM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MUCOADHESIVE FILM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SOLUBLE FILM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SOLUBLE FILM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SOLUBLE FILM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SOLUBLE FILM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SOLUBLE FILM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SOLUBLE FILM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MATRIX PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MATRIX PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MATRIX PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MATRIX PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MATRIX PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONTROLLED-RELEASE TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONTROLLED-RELEASE TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONTROLLED-RELEASE TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONTROLLED-RELEASE TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONTROLLED-RELEASE TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONTROLLED-RELEASE TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INSTANT-RELEASE TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INSTANT-RELEASE TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INSTANT-RELEASE TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INSTANT-RELEASE TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INSTANT-RELEASE TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INSTANT-RELEASE TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BIOADHESIVE GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BIOADHESIVE GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BIOADHESIVE GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BIOADHESIVE GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BIOADHESIVE GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY BIOADHESIVE GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HYDROGEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HYDROGEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HYDROGEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY METERED-DOSE SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY METERED-DOSE SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY METERED-DOSE SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY METERED-DOSE SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY METERED-DOSE SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY METERED-DOSE SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MULTI-DOSE SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MULTI-DOSE SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MULTI-DOSE SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MULTI-DOSE SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MULTI-DOSE SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY MULTI-DOSE SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NICOTINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NICOTINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NICOTINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NICOTINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NICOTINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NICOTINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY OPIOIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY OPIOIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONVENTIONAL DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONVENTIONAL DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONVENTIONAL DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONVENTIONAL DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONVENTIONAL DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CONVENTIONAL DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NANOPARTICLE ENHANCED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NANOPARTICLE ENHANCED DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NANOPARTICLE ENHANCED DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NANOPARTICLE ENHANCED DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NANOPARTICLE ENHANCED DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY NANOPARTICLE ENHANCED DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ESTROGEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ESTROGEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ESTROGEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ESTROGEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ESTROGEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TESTOSTERONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TESTOSTERONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TESTOSTERONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY TESTOSTERONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIMICROBIAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIMICROBIAL AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIMICROBIAL AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIMICROBIAL AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIMICROBIAL AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIMICROBIAL AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIVIRAL AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIVIRAL AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIVIRAL AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ANTIVIRAL AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ACUTE PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ACUTE PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ACUTE PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ACUTE PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY ACUTE PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SMOKING CESSATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SMOKING CESSATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SMOKING CESSATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY SMOKING CESSATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BUCCAL CAVITY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY HORMONE REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL FILM, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL PATCH, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY BUCCAL TABLET, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY GEL, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY ORAL SPRAY, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY DRUG CLASS, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA BUCCAL CAVITY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA BUCCAL